ARTICLE | Company News
Cytoclonal other research news
March 13, 2000 8:00 AM UTC
CYPH said that it has developed antisense inhibitors of PKC-alpha using its Oasis optimized antisense reagent technology. The company said the inhibitors blocked cancer cell growth in vitro and could...